Releases - RaySearch Laboratories

View:

2009

 

Found press releases

 

RaySearch Laboratories AB (publ) Interim report January 1 – September 30, 2009

11/20/2009 1:45 AM EST
JANUARY 1 – SEPTEMBER, 30 2009
• Net sales for the period amounted to SEK 47.3 M (41.3)
• Profit after tax was SEK 12.6 M (7.3) and earnings per share amounted to SEK 0.37 (0.21)
• Operating profit was SEK 17.1 M (8.0)
• Cash flow totaled SEK 5.4 M (neg: 20.0)
• The first product from the collaboration with TomoTherapy received FDA clearance in January and has been launched
• Three products from the...

Conversion of shares

8/28/2009 3:00 AM EST
According to RaySearch’s articles of association, owners of Class A shares have the right to have such shares converted to Class B shares. Conversion reduces the total number of votes in the company.

In August, at the request of shareholders, 252,756 Class A shares were converted to Class B shares. The total number of votes in the company thereafter amounts to 145,756,485.

The total number of registered shares in...

RaySearch Laboratories AB (publ) Interim Report January 1 – June 30, 2009

8/27/2009 1:45 AM EST
JANUARY 1 – JUNE 30, 2009
• Net sales for the period amounted to SEK 34.7 M (27.6)
• Profit after tax was SEK 12.3 M (4.2) and earnings per share amounted to SEK 0.36 (0.12)
• Operating profit was SEK 16.6 M (4.4)
• Cash flow totaled SEK 1.8 M (neg: 15.1)
• The collaboration with Nucletron was extended in January with two new products for treatment planning
• The first product from the collaboration with...

RaySearch wins breakthrough order for proton treatment planning system

7/2/2009 3:00 AM EST
RaySearch Laboratories AB (publ.) has entered into a partnership and licensing agreement with Westdeutsches Protonentherapiezentrum Essen gGmbH (WPE). WPE is a proton therapy center under construction at the University Hospital in Essen, Germany. Proton therapy is an advanced form of radiation therapy and is a highly effective method to selectively irradiate tumors and at the same time spare surrounding healthy...

Three products from collaboration between RaySearch and Varian have been launche...

7/1/2009 5:24 AM EST
RaySearch Laboratories AB announces today that three new software solutions from the collaboration with Varian Medical Systems (NYSE: VAR) have been launched. The products are integrated as modules in the latest release of Varian’s Eclipse™ treatment planning system, which recently received 510(k) clearance from the FDA.

The products are treatment planning software modules for optimization of conventional...

Resolutions at Annual General Meeting of RaySearch Laboratories AB (publ)

5/26/2009 2:27 PM EST
The Annual General Meeting of RaySearch Laboratories AB (publ), which was held on May 26, 2009, passed the following resolutions, among others.

It was resolved that the number of Board members shall be four (4) and the number of deputy members shall be one (1). Johan Löf, Erik Hedlund, Carl Filip Bergendal and Hans Wigzell were re-elected members of the Board, with Erik Hedlund as Chairman of the Board. Thomas...

RaySearch Laboratories AB (publ) Interim Report January 1- March 31, 2009

5/15/2009 1:45 AM EST
JANUARY 1 – MARCH 31, 2009
• Net sales for the period totaled SEK 16.9 M (15.6)
• Profit after tax was SEK 7.3 M (3.1) and earnings per share amounted to SEK 0.21 (0.09)
• Operating profit was SEK 9.9 M (3.6)
• Cash flow totaled SEK 8.7 M (neg: 5.5)
• The collaboration with Nucletron was extended in January with two new products for treatment planning
• The first product from the collaboration with...

RaySearch enters partnership with Siemens

5/15/2009 1:40 AM EST
RaySearch Laboratories AB (publ.) has entered into a long-term development and licensing agreement with Siemens Healthcare. This new collaboration means that RaySearch will provide a number of treatment planning modules aimed at improving radiation therapy. The software modules will be integrated in Siemens’ syngo® Suite for Oncology, which is Siemens’ integrated workflow solution for radiation therapy.

“We are...

Invitation to Annual General Meeting 2009

4/29/2009 5:49 AM EST
Shareholders in RaySearch Laboratories AB (publ) are hereby invited to the Annual General Meeting on Tuesday 26 May 2009 at 6:00 p.m., in Kammarsalen at the Berns Conference Center, Berzelii Park, Stockholm, Sweden.

NOTICE, ETC.

Shareholders who wish to participate in the Annual General Meeting, must:

- be recorded in the share register maintained by Eucroclear Sweden AB (Euroclear) not later than Tuesday...

SharePlan has been launched

4/29/2009 4:31 AM EST
RaySearch Laboratories AB announced today that the new software solution SharePlan™ has been launched on the market. SharePlan™ is the first product emanating from a collaboration that was entered between RaySearch and TomoTherapy in 2007. As previously announced, the product received 510(k) clearance in January and now TomoTherapy will start taking orders.

SharePlan™ is an advanced treatment planning solution...

RaySearch Laboratories

RaySearch Laboratories is a medical technology company that develops advanced software solutions for improved radiation therapy of cancer. RaySearch’s products are sold through license agreements with leading partners su...

View more


  CONTACT